Association between non-alcoholic fatty liver disease and autonomic dysfunction in a Chinese population

QJM: An International Journal of Medicine

Volumn 108, Issue 8, 2015, Pages 617-624

  Sun, W ^a,b   Zhang, D ^a,b   Sun, J ^a,b   Xu, B ^a,b   Sun, K ^a,b   Wang, T ^a,b   Ren, C ^a,b   Li, J ^a,b   Chen, Y ^a,b   Xu, M ^a,b   Bi, Y ^a,b   Xu, Q ^b   Wang, W ^a,b   Gu, Y ^a,b   Ning, G ^a,b  

^a BEIJING HOSPITAL   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHLORIDE; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN; LIVER ENZYME; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; AUTONOMIC DYSFUNCTION; B SCAN; BODY MASS; CHINESE; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ELECTROCHEMICAL DETECTION; ELECTROCHEMICAL SKIN CONDUCTANCE; FEMALE; FUNCTIONAL ASSESSMENT; GLUCOSE BLOOD LEVEL; HEPATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; POPULATION; PREVALENCE; PRIORITY JOURNAL; SEX ALLOCATION; SKIN CONDUCTANCE; SWEAT GLAND FUNCTION; ULTRASOUND SCANNER; AGED; AUTONOMIC NERVOUS SYSTEM DISEASES; CHINA; COMPLICATION; ECHOGRAPHY; ELECTRODERMAL RESPONSE; NON-ALCOHOLIC FATTY LIVER DISEASE; RISK FACTOR;

ADULT; AGED; AUTONOMIC NERVOUS SYSTEM DISEASES; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; GALVANIC SKIN RESPONSE; HUMANS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PREVALENCE; RISK FACTORS;

EID: 84939531876     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcv006     Document Type: Article

References (42)

1. Thuluvath PJ, Triger DR. autonomic neuropathy and chronic liver disease. Q J Med 1989; 72:737-47.
2. Newton JL, Hudson M, Tachtatzis P, Sutcliffe K, Pairman J, Burt JA, et al. Population prevalence and symptom associations of autonomic dysfunction in primary biliary cirrhosis. Hepatology 2007; 45:1496-505.
3. Chaudhry V, Corse AM, O'Brian R, Cornblath DR, Klein AS, Thuluvath PJ. Autonomic and peripheral (sensorimotor) neuropathy in chronic liver disease: a clinical and electrophysiologic study. Hepatology 1999; 29:1698-703.
4. Hendrickse MT, Thuluvath PJ, Triger DR. Natural history of autonomic neuropathy in chronic liver disease. Lancet 1992; 339:1462-4.
5. Frith J, Newton JL. Autonomic dysfunction in chronic liver disease. Liver Int 2009; 29:483-9.
6. Liu W, Baker SS, Baker RD, Nowak NJ, Zhu L. Upregulation of Hemoglobin Expression by Oxidative Stress in Hepatocytes and Its Implication in Nonalcoholic Steatohepatitis. PLoS One 2011; 6:e24363.
7. Hsu Y-H, Venners SA, Terwedow HA, Feng Y, Niu T, Li Z, et al. Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women. Am J Clin Nutr 2006; 83:146-54.
8. Day CP. Non-alcoholic fatty liver disease: current concepts and management strategies. Clin Med 2006; 6:19-25.
9. Marchesini G, Marzocchi R, Agostini F, Bugianesi E. Nonalcoholic fatty liver disease and the metabolic syndrome. Curr Opin Lipidol 2005; 16:421-7.
10. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999; 30:1356-62.
11. Gebel E. Finding the nerve: diabetic neuropathy often goes undercover, but doctors have ways to unmask it. Diabetes Forecast 2013; 66:30-2.
12. Low PA. Evaluation of sudomotor function. Clin Neurophysiol 2004; 115:1506-13.
13. Singer W, Spies JM, McArthur J, Low J, Griffin JW, Nickander KK, et al. Prospective evaluation of somatic and autonomic small fibers in selected autonomic neuropathies. Neurology 2004; 62:612-8.
14. Low VA, Sandroni P, Fealey RD, Low PA. Detection of smallfiber neuropathy by sudomotor testing. Muscle Nerve 2006; 34:57-61.
15. Xiong L, Leung HW, Chen XY, Leung WH, Soo OY, Wong KS. Autonomic dysfunction in different subtypes of post-acute ischemic stroke. J Neurol Sci 2014; 337:141-6.
16. The IPAQ group. International physical activity questionnarie. 2014. http://www.ipaq.ki.se/scoring.pdf (accessed 10 December 2014, date last accessed).
17. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bel-lentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005; 42:44-52.
18. Li Y, Xu C, Yu C, Xu L, Miao M. Association of serum uric acid level with non-alcoholic fatty liver disease: a crosssectional study. J Hepatol 2009; 50:1029-34.
19. Farrell GC, Chitturi S, Lau GK, Sollano JD. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol 2007; 22:775-7.
20. Ramachandran A, Moses A, Shetty S, Thirupurasundari CJ, Seeli AC, Snehalatha C, et al. A new non-invasive technology to screen for dysglycaemia including diabetes. Diabetes Res Clin Pract 2010; 88:302-6.
21. Mayaudon H, Miloche PO, Bauduceau B. A new simple method for assessing sudomotor function: relevance in type 2 diabetes. Diabetes Metab 2010; 36:450-4.
22. Sun K, Liu Y, Dai M, Li M, Yang Z, Xu M, et al. Accessing autonomic function can early screen metabolic syndrome. PLoS One 2012; 7:e43449.
23. Chizmadzhev YA, Indenbom AV, Kuzmin PI, Galichenko SV, Weaver JC, Potts RO. Electrical properties of skin at moderate voltages: contribution of appendageal macropores. Biophys J 1998; 74:843-56.
24. Brunswick P, Mayaudon H, Albin V, Lair V, Ringuede A, Cassir M. Use of Ni electrodes chronoamperometry for improved diagnostics of diabetes and cardiac diseases. In:Engineering in Medicine and Biology Society, 2007 EMBS 2007 29th Annual International Conference of the IEEE; 22-26 August 2007, pp. 4544-7, Lyon, IEEE.
25. Yang Z, Xu B, Lu J, Tian X, Li M, Sun K, et al. Autonomic test by EZSCAN in the screening for prediabetes and diabetes. PLoS One 2013; 8:e56480.
26. Carey EJ, Gautam M, Ingall T, Douglas DD. The effect of liver transplantation on autonomic dysfunction in patients with endstage liver disease. Liver Transplantation 2008; 14:235-9.
27. Hendrickse MT, Thuluvath PJ, Triger DR. Natural history of autonomic neuropathy in chronic liver disease. Lancet 1992; 339:1462-4.
28. Gentile S, Marmo R, Peduto A, Montella F, Coltorti M. Autonomic neuropathy in liver cirrhosis: relationship with alcoholic etiology and severity of disease. Ital J Gastroenterol 1994; 89:1544-7.
29. McDougall AJ, Davies L, McCaughan GW. Autonomic and peripheral neuropathy in endstage liver disease and following liver transplantation. Muscle Nerve 2003; 28:595-600.
30. Fleckenstein JF, Frank S, Thuluvath PJ. Presence of autonomic neuropathy is a poor prognostic indicator in patients with advanced liver disease. Hepatology 1996; 23:471-5.
31. Angulo P. GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther 2007; 25:883-9.
32. Williams R. Global challenges in liver disease. Hepatology 2006; 44:521-6.
33. Lhuillier F, Dalmas ED, Gratadour PM, Cividjian AA, Boillot OC, Quintin L, et al. Spontaneous barore-flex cardiac sensitivity in end-stage liver disease: effect of liver transplantation. Eur J Anaesthesiol 2006; 23:426-32.
34. Low PA, Caskey PE, Tuck RR, Fealey RD, Dyck PJ. Quantitative sudomotor axon reflex test in normal and neuropathic subjects. Ann Neurol 1983; 14:573-80.
35. Berger JR, Ayyar R, Sheremata WA. Guillain-Barre syndrome complicating acute hepatitis B. A case with detailed electrophysiological and immunological studies. Arch Neurol 1981; 38:366-8.
36. Miyaaki H, Ichikawa T, Nakao K, Yatsuhashi H, Furukawa R, Ohba K, et al. Clinicopathological study of nonalcoholic fatty liver disease in Japan: the risk factors for fibrosis. Liver Int 2008; 28:519-24.
37. Kingston ME, Ali MA, Atiyeh M, Donnelly RJ. Diabetes mellitus in chronic active hepatitis and cirrhosis. Gastroenterology 1984; 87:688-94.
38. Ramachandran A, Moses A, Shetty S, Thirupurasundari CJ, Seeli AC, Snehalatha C, et al. A new non-invasive technology to screen for dysglycaemia including diabetes. Diabetes Res Clin Pract 2010; 88:302-6.
39. Mayaudon H, Miloche PO, Bauduceau B. A new simple method for assessing sudomotor function: relevance in type 2 diabetes. Diabetes Metab 2010; 36:450-4.
40. Amarapurkar DN, Hashimoto E, Lesmana LA, Sollano JD, Chen PJ, Goh KL. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? J Gastroenterol Hepatol 2007; 22:788-93.
41. Yajima Y, Ohta K, Narui T, Abe R, Suzuki H, Ohtsuki M. Ultrasonographical diagnosis of fatty liver: significance of the liver-kidney contrast. Tohoku J Exp Med 1983; 139:43-50.
42. Joseph AE, Saverymuttu SH, al-Sam S, Cook MG, Maxwell JD. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 1991; 43:26-31.